Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management

SYC Tong, JS Davis, E Eichenberger… - Clinical microbiology …, 2015 - Am Soc Microbiol
Staphylococcus aureus is a major human pathogen that causes a wide range of clinical
infections. It is a leading cause of bacteremia and infective endocarditis as well as …

The double burden of diabetes and global infection in low and middle-income countries

S Dunachie, P Chamnan - Transactions of The Royal Society of …, 2019 - academic.oup.com
Four out of five people in the world with diabetes now live in low-and middle-income
countries (LMIC), and the incidence of diabetes is accelerating in poorer communities …

Systemic Staphylococcus aureus infection mediated by Candida albicans hyphal invasion of mucosal tissue

LM Schlecht, BM Peters, BP Krom… - …, 2015 - microbiologyresearch.org
Candida albicans and Staphylococcus aureus are often co-isolated in cases of biofilm-
associated infections. C. albicans can cause systemic disease through morphological switch …

Current concepts on the virulence mechanisms of meticillin-resistant Staphylococcus aureus

RR Watkins, MZ David… - Journal of medical …, 2012 - microbiologyresearch.org
Meticillin-resistant Staphylococcus aureus (MRSA) strains are prevalent bacterial pathogens
that cause both health care and community-associated infections. Increasing resistance to …

Escherichia coli and Staphylococcus aureus: leading bacterial pathogens of healthcare associated infections and bacteremia in older-age populations

JT Poolman, AS Anderson - Expert Review of Vaccines, 2018 - Taylor & Francis
Introduction: Bacteremia and healthcare-associated infections (HAIs) continue to rise in
industrialized countries, in line with population aging and increased healthcare needs …

Virulence strategies of the dominant USA300 lineage of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)

LR Thurlow, GS Joshi… - FEMS Immunology & …, 2012 - academic.oup.com
Methicillin-resistant Staphylococcus aureus (MRSA) poses a serious threat to worldwide
health. Historically, MRSA clones have strictly been associated with hospital settings, and …

Improved understanding of factors driving methicillin-resistant Staphylococcus aureus epidemic waves

SS Chatterjee, M Otto - Clinical epidemiology, 2013 - Taylor & Francis
Methicillin-resistant Staphylococcus aureus (MRSA) remains one of the most important
causes of nosocomial infections worldwide. Since the global spread of MRSA in the 1960s …

Bloodstream infections in the intensive care unit

M Bassetti, E Righi, A Carnelutti - Virulence, 2016 - Taylor & Francis
Bloodstream infections (BSIs) represent a common complication among critically ill patients
and a leading cause of morbidity and mortality. The prompt initiation of an effective antibiotic …

A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study

LK Yaw, JO Robinson, KM Ho - The Lancet Infectious Diseases, 2014 - thelancet.com
Background Findings from previous studies have suggested that outcomes after meticillin-
resistant Staphylococcus aureus (MRSA) bacteraemia are worse than after meticillin …

Prevalence, predictors, and mortality of bloodstream infections due to methicillin-resistant Staphylococcus aureus in patients with malignancy: systemic review and …

Z Li, H Zhuang, G Wang, H Wang, Y Dong - BMC infectious diseases, 2021 - Springer
Background Cancer patients are more likely to develop and die of bloodstream infection
(BSI) than noncancer patients. Methicillin-resistant Staphylococcus aureus (MRSA), which is …